Stem cell clonality and genotoxicity in hematopoietic cells: Gene activation side effects should be avoidable

Seminars in Hematology

Volumn 41, Issue 4 SPEC.ISS., 2004, Pages 303-318

  Von Kalle, C ^a,b,e   Fehse, B ^c   Layh Schmitt, G ^a   Schmidt, M ^b   Kelly, P ^a   Baum, C ^a,d  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e Molecular and Gene Therapy Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; BUSULFAN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR GAMMA; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ADENOSINE DEAMINASE DEFICIENCY; CANCER RISK; CELL TYPE; CLINICAL TRIAL; CLONAL VARIATION; COMBINED IMMUNODEFICIENCY; ENZYME DEFICIENCY; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INSERTION; GENE SEQUENCE; GENE TARGETING; GENOTOXICITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LMO2 ONCOGENE; LYMPHATIC LEUKEMIA; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTO ONCOGENE; REVIEW; RISK ASSESSMENT; TRANSGENE; UMBILICAL CORD BLOOD; X CHROMOSOME LINKED DISORDER;

EID: 7044253288     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2004.07.007     Document Type: Article

References (150)

1. C.E. Dunbar, N.S. Young Gene marking and gene therapy directed at primary hematopoietic cells Curr Opin Hematol 3 1996 430 437
2. S. Hacein-Bey-Abina, F. Le Deist, F. Carlier, C. Bouneaud, C. Hue, P. De Villartay Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy N Engl J Med 18 2002 1185 1193
3. A. Aiuti, S. Slavin, M. Aker, F. Ficara, S. Deola, A. Mortellaro, S. Morecki Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning Science 296 2002 2410 2413
4. T. Neff, P.A. Horn, L.J. Peterson, B.M. Thomasson, J. Thompson, D.A. Williams Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model J Clin Invest 112 2003 1581 1588
5. + cells in ADA-deficient SCID neonates Nat Med 4 1998 775 780
6. S. Hacein-Bey-Abina, C. von Kalle, M. Schmidt, M.P. McCormack, N. Wulffraat, P. Leboulch LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415 419
7. B. Royer-Pokora, U. Loos, W.-D. Ludwig TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11) Oncogene 6 1991 1887 1893
8. I.A. Wadman, H. Osada, G.G. Grutz, A.D. Agulnick, H. Westphal, A. Forster The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NL1 proteins EMBO J 16 1997 3145 3157
9. G.G. Gruetz, K. Bucher, I. Lavenir, T. Larson, R. Larson, T.H. Rabbitts The oncogenic T cell LIM-protein LMO-2 forms part of a DNA-binding complex specifically in immature T cells EMBO J 17 1998 4594 4605
10. E. Lecuyer, S. Herblot, M. Saint-Denis, R. Martin, C.G. Begley, C. Porcher The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1 Blood 100 2002 2430 2440
11. Z. Xu, S. Huang, L.S. Chang, A.D. Agulnick, S.J. Brandt Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation Mol Cell Biol 23 2003 7585 7599
12. S. Herblot, A.M. Steff, P. Hugo, P.D. Aplan, T. Hoang SCL and LMO1 alter thymocyte differentiation Inhibition of E2A-HEB function and pre-T alpha chain expression Nat Immunol 1 2000 138 144
13. M.P. McCormack, A. Forster, L. Drynan, R. Pannell, T.H. Rabbitts The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development Mol Cell Biol 23 2003 9003 9013
14. S.C. Crable, K.P. Anderson A PAR domain transcription factor is involved in the expression from a hematopoietic-specific promoter for the human LMO2 gene Blood 101 2003 4757 4764
15. M.P. McCormack, T.H. Rabbitts Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency N Engl J Med 26 2004 913 922
16. OMIM, http://www.ncbi.nlm.nih.gov
17. C. Baum, J. Düllmann, Z. Li, B. Fehse, J. Meyer, D.A. Williams Side effects of retroviral gene transfer into hematopoietic stem cells Blood 101 2003 2099 2114
18. R. Pawliuk, K.A. Westerman, M.E. Fabry, E. Payen, R. Tighe, E.E. Bouhassira Correction of sickle cell disease in transgenic mouse models by gene therapy Science 294 2001 2368 2371
19. F.D. Bushman Lateral DNA Transfer Mechanisms and Consequences 2001 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
20. A.V. Rynditch, S. Zoubak, L. Tsyba, N. Tryapitsina-Guley, G. Bernardi The regional integration of retroviral sequences into the mosaic genomes of mammals Gene 22 1998 1 16
21. J.M. Coffin, S.H. Hughes, H.E. Varmus Retroviruses 1997 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
22. S. Vjjaya, D.L. Steffan, H.L. Robinson Acceptor sites for retroviral integrations map near Dnasel-hypersensitive sites in chromatin J Virol 60 1986 683 692
23. K. Mooslehner, U. Karls, K. Harbers Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions J Virol 64 1990 3056 3058
24. U. Scherdin, K. Rhodes, M. Breindl Transcriptionally active genome regions are preferred targets for retrovirus integration J Virol 64 1990 907 912
25. S. Carteau, C. Hoffmann, F.D. Bushman Chromosome structure and HIV-1 cDNA integration Centromeric alphoid repeats are a disfavored target J Virol 72 1998 4005 4014
26. I. Leclercq, F. Mortreux, M. Cavrois Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo J Virol 74 2000 2305 2312
27. J.B. Weidhaas, E.L. Angelichio, S. Fenner Relationship between retroviral DNA integration and gene expression J Virol 74 2000 8382 8389
28. D. Pruss, F.D. Bushman, A.P. Wolffe Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core Proc Natl Acad Sci USA 91 1994 5913 5917
29. R.A. Katz, P. DiCandeloro, G. Kukolj Role of DNA end distortion in catalysis by avian sarcoma virus integrase J Biol Chem 276 2001 34213 34220
30. B.P. Scottoline, S. Chow, V. Ellison Disruption of the terminal base pairs of retroviral DNA during integration Genes Dev 11 1997 371 382
31. A.R. Schroder, P. Shinn, H. Chen HIV-1 integration in the human genome favors active genes and local hotspots Cell 110 2002 521 529
32. X. Wu, Y. Li, B. Crise, S.M. Burgess Transcription start regions in the human genome are favored targets for MLV integration Science 300 2003 1749 1751
33. K. Akagi, T. Suzuki, R.M. Stephens, N.A. Jenkins, N.G. Copeland RTCGD Retroviral tagged cancer gene database Nucleic Acids Res 32 2004 D523 D527
34. H. Mikkers, A. Berns Retroviral insertional mutagenesis Tagging cancer pathways Adv Cancer Res 88 2003 53 99
35. R.E. Donahue, S.W. Kessler, D. Bodine, K. McDonagh, C. Dunbar, S. Goodman Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer J Exp Med 176 1992 1125 1135
36. A.B. Sorensen, M. Duch, P. Jorgenses Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method J Virol 67 1993 7118 7124
37. D.H. Jones, S.C. Winistorfer Sequence specific generation of a DNA panhandle permits PCR amplification of unknown flanking DNA Nucl Acids Res 20 1992 595 600
38. J. Silver, V. Keerikatte Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus J Virol 63 1989 1924 1928
39. M. Lagerström, J. Parik, H. Malmgren Capture PCR Efficient amplification of DNA fragments adjacent to a known sequence in human and YAC DNA Genome Res 1 1991 111 119
40. P.J.M. Valk, M. Joosten, Y. Vankan A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites Nucleic Acids Res 25 1997 4419 4421
41. E.K. Hui, P.C. Wang Strategies for cloning unknown cellular flanking DNA sequences from foreign integrants Cell Mol Life Sci 54 1998 1403 1411
42. D. Dilloo, D.R. Rill, M.E. Grossmann Gene marking and gene therapy for transplantation medicine J Hematol 5 1996 553 555
43. C.E. Dunbar, N.S. Young Gene marking and gene therapy directed at primary hematopoietic cells Curr Opin Hematol 3 1996 430 437
44. M.A. Dao, J.A. Nolta Use of the bnx/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction Int J Mol Med 1 1998 257 264
45. J.A. Nolta, M.A. Dao, S. Wells Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice Proc Nat Acad Sci USA 93 1996 2414 2419
46. G.P. Pfeifer, S.D. Steigerwald, P.R. Mueller Genomic sequencing and methylation analysis by ligation mediated PCR Science 246 1989 810 813
47. P.R. Mueller, B. Wold In vivo footprinting of a muscle specific enhancer by ligation mediated PCR Science 246 1989 780 786
48. Z. Izsvak, Z. Ivics Two-stage ligation-mediated PCR enhances the detection of integrated transgenic DNA Biotechniques 15 1993 814 817
49. H. Eggert, K. Bergemann, H. Saumweber Molecular screening for P-element insertions in a large genomic region of Drosophila melanogaster using polymerase chain reaction mediated by the vectorette Genetics 149 1998 1427 1434
50. G. Prod'hom, B. Lagier, V. Pelicic A reliable amplification technique for the characterization of genomic DNA-sequences flanking insertion sequences FEMSMicrobiology Letters 158 1998 75 81
51. M. Urata, M. Wakiyama, M. Iwase New sensitive method for the detection of the A3243G mutation of human mitochondrial deoxyribonucleid acid in diabetes mellitus patients by ligation-mediated polymerase chain reaction Clin Chem 44 1998 2088 2093
52. J.M. Schupp, L.B. Price, A. Klevytska Internal and flanking sequence from AFLP fragments using ligation-mediated suppression PCR Biotechniques 26 1999 905 912
53. M. Schmidt, P. Zickler, G. Hoffman, S. Haas, M. Wissler, A. Muessig Polyclonal long-term repopulating stem cell clones in a primate model Blood 8 2002 2737 2743
54. Z. Li, J. Düllmann, B. Schiedlmeier, M. Schmidt, C. von Kalle, J. Meyer Murine leukemia induced by retroviral gene marking Science 296 2002 497
55. K. Kuramoto, D.A. Follmann, P. Hematti, S. Sellers, B.A. Agricola, M.E. Metzger The impact of chronic cytokine therapy on clonal dynamics in non-human primates Blood 103 2004 4070 4077
56. + cells in ADA-deficient SCID neonates Nat Med 4 1998 775 780
57. M. Schmidt, D.A. Carbonaro, C. Speckmann, M. Wissler, J. Bohnsack, M. Elder Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates Nat Med 9 2003 463 468
58. S. Laufs, B. Gentner, K.Z. Nagy, A. Jauch, A. Benner, S. Naundorf Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells Blood 101 2003 2191 2198
59. C. Bartholomew, J.N. Ihle Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter Mol Cell Biol 11 1991 1820 1828
60. D. Carter, L. Chakalova, C.S. Osborne, Y.F. Dai, P. Fraser Long-range chromatin regulatory interactions in vivo Nat Genet 32 2002 623 626
61. H.P. Kiem, S. Sellers, B. Thomasson, J.C. Morris, J.F. Tisdale, P.A. Horn Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells No Progression to Clonal Hematopoiesis or Leukemia Mol Ther 9 2004 389 395
62. B. Fehse, O.S. Kustikova, M. Bubenheim, C. Baum Pois(s)on--It's a question of dose Gene Ther 11 2004 878 881
63. O.S. Kustikova, A. Wahlers, K. Kühlcke, B. Stähle, A.R. Zander, C. Baum Dose finding with retroviral vectors Correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population Blood 102 2003 3934 3937
64. M. Cavazzana-Calvo, A. Thrasher, F. Mavilio The future of gene therapy Balancing the risks and benefits of clinical trials Nature 427 2004 779 922
65. O. Bezzubova, A. Silbergleit, Iwai Y. Yamaguchi, S. Takeda, J.M. Buerstedde Reduced x-ray resistance and homologous recombination frequencies in a RAD54-/- mutant of the chicken DT40 cell line Cell 89 1997 185 193
66. F.D. Bushman Targeting survival integration site selection by retroviruses and LTR-retrotransposons Cell 115 2003 135 138
67. W.M. Rideout, K. Hochedlinger, M. Kyba, G.Q. Daley, R. Jaenisch Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy Cell 109 2002 17 27
68. K. Ghosh, G.D. Van Duyne Cre-loxP biochemistry Methods 28 2002 374 383
69. A. Loonstra, M. Vooijs, H.B. Beverloo, B.A. Allak, E. van Drunen, R. Kanaar Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells Proc Natl Acad Sci USA 98 2001 9209 9214
70. R. Daniel, G. Kao, K. Taganov, J.G. Greger, O. Favorova, G. Merkel Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage process Proc Natl Acad Sci USA 100 2003 4778 4783
71. L. Li, M. Olvera, K.E. Yoder, R.S. Mitchell, S.L. Butler, M. Lieber Role of non-homologous DNA end joining pathway in the early steps of retroviral infection EMBO J 12 2001 3272 3281
72. H.J. Kim, J.F. Tisdale, T. Wu, M. Takatoku, S.E. Sellers, P. Zickler Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates Blood 96 2000 1 8
73. T. Reya, S.J. Morrison, M.F. Clarke, I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
74. J.E. Dick Breast cancer stem cells revealed Proc Natl Acad Sci USA 100 2003 3547 3549
75. C.E. Dunbar, M. Takatoku, R.E. Donahue The impact of ex vivo cytokine stimulation on engraftment of primitive hematopoietic cells in a non-human primate model Ann NY Acad Sci 938 2001 236 244
76. M. Takatoku, S. Sellers, B.A. Agricola, M.E. Metzger, I. Kato, R.E. Donahue Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates J Clin Invest 108 2001 447 455
77. F.A. Ayuk, A.R. Zander, B. Fehse T lymphocytes as targets of gene transfer with Moloney type retroviral vectors Curr Gene Ther 1 2001 325 337
78. C. Berger, C.A. Blau, T. Clackson, S.R. Riddell, S. Heimfeld CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy Blood 101 2003 476 484
79. R.C. Allsopp, I.L. Weissman Replicative senescence of hematopoietic stem cells during serial transplantation Does telomere shortening play a role? Oncogene 21 2002 3270 3273
80. C.E. Thomas, A. Ehrhardt, M.A. Kay Progress and problems with the use of viral vectors for gene therapy Nat Rev Genet 4 2003 346 358
81. X.Q. Yan, D.L. Lacey, C. Saris, S. Mu, D. Hill, R.G. Hawley Ectopic overexpression of c-mpl by retroviral-mediated gene transfer suppressed megakaryopoiesis but enhanced erythropoiesis in mice Exp Hemat 27 1999 1409 1417
82. M. Onishi, A.L. Mui, Y. Morikawa, L. Cho, S. Kinoshita, G.P. Nolan Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer Blood 88 1996 1399 1406
83. H. Neff Efficient in vivo selection of hematopoietic stem cells in a large animal model using MGMT and O6BG/temozolomide Mol Ther 7 2003 S155 (abstr)
84. L. Jin, H. Zeng, S. Chien, K.G. Otto, R.E. Richard, D.W. Emery In vivo selection using a cell-growth switch Nat Genet 26 2000 64 66
85. C. Klein, D. Nguyen, C.H. Liu, A. Mizoguchi, A.K. Bhan, H. Miki Gene therapy for Wiskott-Aldrich syndrome Rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice Blood 101 2003 2159 2166
86. U. Davé, N.A. Jenkins, N.G. Copeland Gene therapy insertional mutagenesis insights Science 303 2004 333
87. S. Hacein-Bey-Abina, F. Le Deist, F. Carlier, C. Bouneaud, C. Hue, J.P. De Villartay Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy N Engl J Med 346 2002 1185 1193
88. F. Candotti, S.A. Oakes, J.A. Johnston, S. Giliani, R.F. Schumacher, P. Mella Structural and functional basis for JAK3-deficient severe combined immunodeficiency Blood 90 1997 3996 4003
89. K.D. Bunting, M.Y. Sangster, J.N. Ihle, B.P. Sorrentino Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer Nat Med 4 1998 58 64
90. T.S. Migone, J.X. Lin, A. Cereseto, J.C. Mulloy, J.J. O'Shea, G. Franchini Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1 Science 269 1995 79 81
91. E.A. Sudbeck, X.P. Liu, R.K. Narla, S. Mahajan, S. Ghosh, C. Mao Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents Clin Cancer Res 5 1999 1569 1582
92. M. Otsu, S.M. Anderson, D.M. Bodine, J.M. Puck, J.J. O'Shea, F. Candotti Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy Mol Ther 1 2000 145 153
93. N. Taylor, K.B. Bacon, S. Smith, T. Jahn, T.A. Kadlecek, L. Uribe Reconstitution of T cell receptor signaling in ZAP-70-deficient cells by retroviral transduction of the ZAP-70 gene J Exp Med 184 1996 2031 2036
94. C.M. Roifman, J. Zhang, D. Chitayat, N. Sharfe A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency Blood 96 2000 2803 2807
95. J. Antonchuk, G. Sauvageau, R.K. Humphries HOXB4-induced expansion of adult hematopoietic stem cells ex vivo Cell 109 2002 39 45
96. B. Schiedlmeier, H. Klump, E. Will, G. Arman Kalcek, Z. Li, Z. Wang High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation Blood. 101 2003 1759 1768
97. C. Buske, R.K. Humphries Homeobox genes in leukemogenesis Int J Hematol 71 2000 301 308
98. P.A. Hantzopoulos, C. Suri, D.J. Glass, M.P. Goldfarb, G.D. Yancopoulos The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins Neuron 13 1994 187 201
99. I. Hamaguchi, J. Flygare, H. Nishiura, A.C. Brun, A. Ooka, T. Kiefer Proliferation deficiency of multipotent hematopoietic progenitors in ribosomal protein S19 (RPS19)-deficient diamond-Blackfan anemia improves following RPS19 gene transfer Mol Ther 7 2003 613 622
100. K.L. Fu, J.R. Foe, H. Joenje, K.W. Rao, J.M. Liu, C.E. Walsh Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer Blood 90 1997 3296 3303
101. K.A. Gush, K.L. Fu, M. Grompe, C.E. Walsh Phenotypic correction of Fanconi anemia group C knockout mice Blood 95 2000 700 704
102. K. Nakanishi, A. Moran, T. Hays, Y. Kuang, E. Fox, D. Garneau Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9 Exp Hematol 29 2001 842 849
103. H. Hanenberg, S.D. Batish, K.E. Pollok, L. Vieten, P.C. Verlander, C. Leurs Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool Exp Hematol 30 2002 410 420
104. L.S. Haneline, X.C. Li, S.L.M. Ciccone, P. Hong, Y. Yang Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution Blood 101 2003 1299 1307
105. F. Yates, M. Malassis-Seris, D. Stockholm, C. Bouneaud, F. Larousserie, P. Noguiez-Hellin Gene therapy of RAG-2-/- mice sustained correction of the immunodeficiency Blood 100 2002 3942 3949
106. E. Spanopoulou, P. Cortes, C. Shih, C.M. Huang, D.P. Silver, P. Svec Localization, interaction, and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2 Immunity 3 1995 715 726
107. D. Moshous, I. Callebaut, R. de Chasseval, B. Corneo, M. Cavazzana Calvo, F. Le Deist Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency Cell 105 2001 177 186
108. J.A. Allay, L.L. Dumenco, O.N. Koc, L. Liu, S.L. Gerson Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells Blood 85 1995 3342 3351
109. K.D. Bunting ABC transporters as phenotypic markers and functional regulators of stem cells Stem Cells 20 2002 11 20
110. M.C. Lorincz, M.K. Parente, M. Roederer, G.P. Nolan, Z. Diwu, D.I. Martin Single cell analysis and selection of living retrovirus vector-corrected mucopolysaccharidosis VII cells using a fluorescence-activated cell sorting-based assay for mammalian beta-glucuronidase enzymatic activity J Biol Chem 274 1999 657 665
111. + cells from patients with Gaucher disease In vivo detection of transduced cells without myeloablation Hum Gene Ther 9 1998 2629 2640
112. P.H. Correll, Y. Kew, L.K. Perry, R.O. Brady, J.K. Fink, S. Karlsson Expression of human glucocerebrosidase in long-term reconstituted mice following retroviral-mediated gene transfer into hematopoietic stem cells Hum Gene Ther 1 1990 277 287
113. T. Takenaka, G.J. Murray, G. Qin, J.M. Quirk, T. Ohshima, P. Qasba Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells Proc Natl Acad Sci USA 97 2000 7515 7520
114. U. Matzner, D. Hartmann, Rauch R. Lullmann, R. Coenen, F. Rothert, J.E. Mansson Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy Effects on visceral and nervous system disease manifestations Gene Ther 9 2002 53 63
115. C. Fillat, C.M. Simonaro, P.L. Yeyati, J.L. Abkowitz, M.E. Haskins, E.H. Schuchman Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy J Clin Invest 98 1996 497 502
116. S. Erlich, S.R. Miranda, J.W. Visser, A. Dagan, S. Gatt, E.H. Schuchman Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice Implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures Blood 93 1999 80 86
117. D. Pan, E. Aronovich, R.S. McIvor, C.B. Whitley Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I Gene Ther 7 2000 1875 1883
118. E. Richard, M. Mendez, F. Mazurier, C. Morel, P. Costet, P. Xia Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection Mol Ther 4 2001 331 338
119. M.C. Dinauer, M.A. Gifford, N. Pech, L.L. Li, P. Emshwiller Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease Blood 97 2001 3738 3745
120. M.C. Dinauer, L.L. Li, H. Bjorgvinsdottir, C. Ding, N. Pech Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease Blood 94 1999 914 922
121. R. Pawliuk, K.A. Westerman, M.E. Fabry, E. Payen, R. Tighe, E.E. Bouhassira Correction of sickle cell disease in transgenic mouse models by gene therapy Science 294 2001 2368 2371
122. C. May, S. Rivella, J. Callegari, G. Heller, K.M. Gaensler, L. Luzzatto Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin Nature 406 2000 82 86
123. C. May, S. Rivella, A. Chadburn, M. Sadelain Successful treatment of murine beta- thalassemia intermedia by transfer of the human beta-globin gene Blood 99 2002 1902 1908
124. A. Aiuti, S. Slavin, M. Aker, F. Ficara, S. Deola, A. Mortellaro Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning Science 296 2002 2410 2413
125. + cells from the cord blood of ADA-deficient SCID neonates Nat Med 9 2003 463 468
126. D.M. Nelson, K.A. Butters, M.L. Markert, N.L. Reinsmoen, R.S. McIvor Correction of proliferative responses in purine nucleoside phosphorylase (PNP)-deficient T lymphocytes by retroviral-mediated PNP gene transfer and expression J Immunol 154 1995 3006 3014
127. D.A. Williams, K. Hsieh, A. DeSilva, R.C. Mulligan Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate- resistant bone marrow J Exp Med 166 1987 210 218
128. J.A. Allay, D.A. Persons, J. Galipeau, J.M. Riberdy, R.A. Ashmun, R.L. Blakley In vivo selection of retrovirally transduced hematopoietic stem cells Nat Med 4 1998 1136 1143
129. J. Antonchuk, G. Sauvageau, R.K. Humphries HOXB4-induced expansion of adult hematopoietic stem cells ex vivo Cell 109 2002 39 45
130. S. Hacein Bey Abina, G. de Saint Basile, M. Cavazzana Calvo Gene therapy of X-linked severe combined immunodeficiency Methods Mol Biol 215 2003 247 259
131. C. Bonini, M. Grez, C. Traversari, F. Ciceri, S. Marktel, G. Ferrari Safety of retroviral gene marking with a truncated NGF receptor Nat Med 9 2003 367 369
132. + cells, but impairs lymphomyeloid differentiation Blood 101 2003 1759 1768
133. K.D. Bunting ABC transporters as phenotypic markers and functional regulators of stem cells Stem Cells 20 2002 11 20
134. W.J. Leonard Cytokines and immunodeficiency diseases Nat Rev Immunol 1 2001 200 208
135. C. Baum, C. von Kalle, F.J. Staal, Z. Li, B. Fehse, M. Schmidt Chance or necessity? Insertional mutagenesis in gene therapy and its consequences Mol Ther 9 2004 5 13
136. L. Jin, H. Zeng, S. Chien, K.G. Otto, R.E. Richard, D.W. Emery In vivo selection using a cell-growth switch Nat Genet 26 2000 64 66
137. J. Brocard, R. Feil, P. Chambon, D. Metzger A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor Nucleic Acids Res 26 1998 4086 4090
138. J. Brocard, R. Feil, P. Chambon, D. Metzger A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor Nucleic Acids Res 26 1998 4086 4090
139. E. Marshall Second child in French trial found to have leukemia Science 299 2003 320
140. B.P. Alter, N.S. Young The bone marrow failure syndromes D.G. Nathan F.A. Oski Hematology of Infancy and Childhood 1997 Saunders Philadelphia, PA 227 335
141. B.P. Alter Fanconi's anaemia and its variability Br J Haematol 85 1993 9 14
142. A.D. Auerbach Fanconi anemia Dermatol Clin 13 1995 41 49
143. J.M. Liu, M. Buchwald, C.E. Walsh, N.S. Young Fanconi anemia and novel strategies for therapy Blood 84 1994 3995 4007
144. A.D. D'Andrea, M. Grompe Molecular biology of Fanconi anemia Implications for diagnosis and therapy Blood 90 1997 1725 1736
145. D.I. Kutler, B. Singh, J. Satagopan, S.D. Batish, M. Berwick A 20 year perspective on the International Fanconi Anemia Registry (IFAR) Blood 101 2003 1249 1256
146. M. Kohli-Kumar, C. Morris, C. DeLaat, J. Sambrano, M. Masterson Bone marrow transplantation in Fanconi anemia using matched sibling donors Blood 84 1994 2050 2054
147. E. Gluckman, A.D. Auerbach, M.M. Horowitz, K.A. Sobocinski, R.C. Ash Bone marrow transplantation for Fanconi anemia Blood 86 1995 2856 2862
148. M. MacMillan, D. Weisdorf, T. DeFor, M.A. Champagne, A.D. Auerbach Marked reduction in graft failure and regimen related toxicity after unrelated donor hematopoietic cell transplantation in patients with Fanconi anemia Impact of disease stage and fludarabine Blood 98 2001 670a (abstr)
149. B.P. Alter Fanconi anemia and malignancies Am J Hematol 53 1996 99 110
150. http://www4.od.nih.gov/oba/rac/minutes/RAC_minutes_12-02.pdf.